Noninvasive Physiological Monitoring Device: Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe
Study summary
This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
Eligibility
Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. In good general health with no evidence of significant medical problems.
2. Fluent in both written and spoken English.
4\. Has provided written informed consent and is willing to comply with study procedures.
Exclusion Criteria:
1. BMI above 30.
2. History of heart, lung, kidney, or liver disease.
3. Diagnosis of asthma, sleep apnea, or use of CPAP.
4. Diabetes mellitus.
5. Clotting disorders.
6. Hemoglobinopathy or history of anemia (ctHb \<12 g/dL for men, \<11 g/dL for women, COHb \>2%).
7. Any serious systemic illness.
8. Current smoker.
9. Injury or abnormality at sensor sites interfering with measurements.
10. History of fainting or vasovagal response.
11. Sensitivity to local anesthesia.
12. Diagnosis of Raynaud's disease.
13. Unacceptable collateral circulation (Allen's test).
14. Pregnant, lactating, or attempting to become pregnant.
15. Unable or unwilling to provide informed consent or comply with study procedures.
16. Any other condition deemed unsuitable by the investigator.
Primary outcome measure(s)
Collection of Hemoglobin and Oxygen Saturation Measurements — From enrollment to the end of treatment up to 8 hours Collect device readings of oxygen saturation and hemoglobin concentration and reference values obtained from arterial blood samples analyzed using a multi-wavelength laboratory oximeter.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.